The global Phosphoramidite Market was valued at USD 1.18 billion in 2024 and is projected to reach USD 2.14 billion by 2032, growing at a CAGR of 7.78%. Factors driving market growth include expanding applications of oligonucleotide-based therapeutics, gene editing tools like CRISPR, and mRNA vaccine development. Custom-modified phosphoramidites and GMP-grade reagents are in demand, shaping the industry. The U.S. phosphoramidite market was valued at USD 373.15 million in 2024 and is expected to reach USD 670.78 million by 2032, growing at a CAGR of 7.63%. The U.S. leads in pharmaceutical R&D, biotech ecosystems, and FDA policies, driving demand. Major players in the market include Thermo Fisher Scientific Inc., Integrated DNA Technologies, TriLink BioTechnologies, and more. Standard research grade phosphoramidites dominated the market at 35.94% in 2024, with GMP-Grade emerging as the fastest-growing segment at a CAGR of 8.51%. DNA phosphoramidites held the largest market share at 36.94% in 2024, while RNA phosphoramidites are the fastest-growing segment at 8.64%. Drug discovery & development led the market in 2024, while Diagnostics Development is the fastest-growing segment at 8.30%. Pharmaceutical & biotechnology companies are the largest end-user segment, while academic & research institutes show the highest growth. North America is expected to retain a leading market share of 40.60% in 2024, while Asia Pacific emerges as the fastest-growing region with the highest CAGR of 8.47%. Recent developments include LGC expanding its fluorescent phosphoramidite product line and IDT launching new RNA phosphoramidites for CRISPR and mRNA synthesis. The report offers insights on production & supply chain, application-level demand mapping, quality & compliance benchmarks, pricing & cost structure analysis, regional distribution & trade flows, and supply chain resilience & risk index. The Phosphoramidite Market Report projects a market size of USD 1.18 billion in 2024, increasing to USD 2.14 billion by 2032 with a CAGR of 7.78%. Key segments include DNA, RNA, and labeled phosphoramidites, with applications in drug discovery, diagnostics, and more. Regional analysis covers North America, Europe, Asia Pacific, Middle East & Africa, and Latin America.

SNS Insider offers complete details of the Phosphoramidite Market Analysis & Outlook, allowing for in-depth research and customization options. For more information or to request customization, contact [email protected]. SNS Insider is a top market research and consulting agency, providing clients with current market data, consumer insights, and opinions to make confident decisions in a changing environment. Utilizing various techniques like surveys, video talks, and focus groups globally.

Read more at GlobeNewswire: Phosphoramidite Market Size to Reach USD 2.14 Billion by